Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness

14 Nov 2023

Abstract excerpt

BACKGROUND: Recently approved treatments and updates to genetic testing recommendations for prostate cancer have created a need for correlated analyses of patient outcomes data via germline genetic mutation status. Genetic registries address these gaps by identifying candidates for recently approved targeted treatments, expanding clinical trial data examining specific gene mutations, and understanding effects of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37964482
DOI: 10.1002/pros.24650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectivenessPMID 37964482Read ↗

Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.Semantic proximity Read ↗

Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.Semantic proximity Read ↗

Evaluation of Different National Comprehensive Cancer Network Clinical Practice Guidelines in Prostate Cancer for Germline Genetic Testing in Localized and Locally Recurrent Prostate CancerSemantic proximity Read ↗

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testingSemantic proximity Read ↗

A patient-driven clinicogenomic partnership through the Metastatic Prostate Cancer ProjectSemantic proximity Read ↗

The role of genetic testing in prostate cancer screening, diagnosis, and treatment.Semantic proximity Read ↗

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesSemantic proximity Read ↗

Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.Semantic proximity Read ↗

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.Semantic proximity Read ↗

Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.Semantic proximity Read ↗

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.Semantic proximity Read ↗

The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.